One eye's AMD severity may affect AMD progression from the non neovascular to exudative form in the fellow eye.

The following is a summary of “Submacular hemorrhage rates following anti-vascular endothelial growth factor injections for ...

Preliminary data from a late stage clinical trial of a retinal implant showed promising results, Science Corporation said ...

CHICAGO -- Availability of a bevacizumab biosimilar for ophthalmic use could eliminate a lower-cost treatment option for a ...

Nutritional supplements that contain curcumin -- a natural anti-inflammatory compound -- may protect the eyes from the ...

There are various factors that may potentially increase the risk of developing AMD, such as advancing age (over 50); having a ...

This NMA bridges the gap between trials for both therapies and compare them to one another based on existing data.

A new statistical models shed light on why some patients can extend the dosing interval with Eylea (aflibercept) from 8 weeks ...

CHICAGO -- An artificial intelligence (AI)-based study of home monitoring for neovascular age-related macular degeneration ...

The fight against Age Related Molecular Degeneration Market is seeing a promising boost. According to a recent analysis, the ...

Data about higher doses that are injected less often come as the original 2-milligram dose of Eylea is facing an increasing ...

The ELEVATUM study showed clinically meaningful improvement in vision and reduction in retinal fluid in people with <a target= ...